Neonatal screening for sickle cell disease: a cost-effectiveness analysis (Q47573569)

4 February 2018

title

Neonatal screening for sickle cell disease: a cost-effectiveness analysis (English)

1 reference

4 February 2018

0 references

4

1 reference

4 February 2018

author name string

Tsevat J

series ordinal

1

1 reference

4 February 2018

Wong JB

series ordinal

2

1 reference

4 February 2018

Pauker SG

series ordinal

3

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 April 1991

1 reference

4 February 2018

The Journal of Pediatrics

published in

1 reference

4 February 2018

volume

118

1 reference

4 February 2018

issue

4 Pt 1

1 reference

4 February 2018

page(s)

546-554

1 reference

4 February 2018

Pneumococcal Meningitis in Sickle-Cell Anemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Early deaths in Jamaican children with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Deaths in children with sickle cell anemia. A clinical analysis of 19 fatal instances in Chicago

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Bacteremia in sickle hemoglobinopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Causes of death in sickle-cell disease in Jamaica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Prevention of pneumococcal infection in children with homozygous sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Sickle-cell anemia and other hemoglobinopathies. Procedures and strategy for screening employing spots of blood on filter paper as specimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Routine screening of umbilical cord blood for sickle cell diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Newborn diagnosis of abnormal hemoglobins from a large municipal hospital in Los Angeles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Frequency of Sickling Disorders in U.S. Blacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Clinical presentation of homozygous sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

The distinction between cost and charges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

Massachusetts Department of Public Health. Cost-benefit analysis of newborn screening for metabolic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

The economic returns to community and hospital screening programs for a genetic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983375-X

10.1016/S0022-3476(05)83375-X

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

1901081

1 reference

4 February 2018